Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds
Research in Pharmaceutical Sciences · 2026-05 · 21 (3) · 375-385
DOI: 10.4103/rps.rps_150_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Pharmaceutical Sciences, online erschienen am 10.05.2026. Verfasst von Majid Azarmi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose: Cancer represents a significant public health challenge and a leading cause of mortality globally. Quinazolinones represent a class of privileged structures that exhibit a broad spectrum of biological activities such as anticancer, antihypertensive, antifungal, antibacterial, and anti-inflammatory properties. In the present study, the synthesis of quinazoline-quinazolinone hybrids as anticancer agents and their cytotoxic evaluation are reported. Experimental approach: Initial studies were done by molecular docking of five analogs of quinazoline- quinazolinone hybrids, erlotinib, and doxorubicin against the epidermal growth factor receptor. Treatment of 3-amino quinazolinone with 4-chloro-2-phenylquinazoline afforded final compounds by the nucleophilic substitution of the chloride with the amine of 3-amino quinazolinone derivatives. The cytotoxic effects of the final compounds were determined in vitro against the MCF-7 cell line using the MTT assay. Findings/Results: Compound 5b (7-hydroxy-2-methyl-3-(2-phenylquinazolin-4-ylamino) quinazolin-4(3H)- one) showed the highest docking score of -10.1 kcal/mol. Additionally, compound 5d (2-methyl-7-nitro-3-(2- phenylquinazolin-4-ylamino) quinazolin-4(3H)-one) exhibited remarkable in-vitro cytotoxic activity at 100 μM against the MCF-7 cells. Conclusion and implications: In the present study, quinazoline-quinazolinone hybrids were synthesized, and their cytotoxic effects on the MCF-7 cell line were evaluated. Among them, compound 5d exhibited the most significant cytotoxic activity. The insertion of a nitro group at the 7 position of quinazolinone enhanced the cytotoxic efficacy against MCF-7 cells, likely attributable to electronic influences. Consequently, this compound could serve as a lead compound in the search for new classes of effective anticancer agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Biochemistry, School of Medicine, Lorestan University of Medical Science, Khorramabad, Iran.
Zitieren
APA
Azarmi, M., Rahimi, S., Hormozi, M., & Rezaeinasab, R. (2026). Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds. Research in Pharmaceutical Sciences, 21(3), 375-385. https://doi.org/10.4103/rps.rps_150_24
Vancouver
Azarmi M, Rahimi S, Hormozi M, Rezaeinasab R. Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds. Research in Pharmaceutical Sciences. 2026;21(3):375-385. doi:10.4103/rps.rps_150_24
BibTeX
@article{Azarmi2026,
author = {Azarmi, Majid and Rahimi, Saman and Hormozi, Maryam and Rezaeinasab, Rezvan},
title = {Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds},
journal = {Research in Pharmaceutical Sciences},
year = {2026},
volume = {21},
number = {3},
pages = {375--385},
doi = {10.4103/rps.rps_150_24}
}
EUVIMED